Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Sands, Be; Peyrin-Biroulet, L; Loftus, Ev; Danese, S; Colombel, Jf; Toruner, M; Jonaitis, L; Abhyankar, B; Chen, J; Rogers, R; Lirio, Ra; Bornstein, Jd; Schreiber, S